New Therapeutic Strategies for Cholesterol Management
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 15169
Special Issue Editor
Interests: cardiovascular medicine; personalized medicine; artificial intelligence; multidisciplinary team care; heart failure
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Treatment of lipid metabolism disorders remains one of the foundations of preventive cardiology, affecting the populational life expectancy and quality. In recent years, owing to the hard work of multidisciplinary teams, we have acquired more resources in our therapeutic arsenal. Additionally, the entire spectrum of scientific research methodologies, including genetic studies, prospective epidemiologic cohort studies, Mendelian randomisation studies, and randomised trials of LDL-C lowering therapies, provided further insights to the impact of lipid profile on the burden of atherosclerotic disease and directly influenced the dynamic development of new therapeutic standards. With those advancements, as reflected in the current ESC 2019 guideline recommendations, patients at high and very high cardiovascular risk should now achieve more restrictive than ever before LDL-C treatment goals (≥50% reduction from baseline and <1.8 mmol/L [<70mg/dL]). On the other hand, many researchers also pursue the early introduction of dyslipidemia management in low-risk populations to reduce the LDL-C exposure and the concomitant atherosclerotic cardiovascular disease burden.
It is my great privilege to invite you to contribute to this Special Issue on cholesterol regulation. I welcome the submission of innovative original research, state-of-the-art reviews, and viewpoints dealing with the novel frontiers and individualized management of dyslipidemias
Dr. Michalina Kołodziejczak
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dyslipidemia
- hypercholesterolemia
- cardiovascular disease risk factors
- lipid-lowering therapy
- lipid disorders
- statins
- PCSK9 inhibition